Clinical Trial Update: Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery [Phase 1]

View source ↗

Summary

A Phase 1 trial update describes light dosimetry for photodynamic therapy using porfimer sodium in participants with malignant mesothelioma or non-small cell lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• Photofrin (porfimer sodium)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Malignant Mesothelioma, Non-Small Cell Lung Carcinoma | Phase 1 | Status: COMPLETED